Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01603966
Other study ID # Val-030
Secondary ID
Status Completed
Phase N/A
First received May 21, 2012
Last updated July 14, 2012
Start date April 2012
Est. completion date June 2012

Study information

Verified date July 2012
Source Aggredyne, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

This study is to determine whether the AggreGuide platelet aggregometer can discern the effect of low dose aspirin on subjects platelet aggregation using arachidonic acid as the agonist.


Recruitment information / eligibility

Status Completed
Enrollment 13
Est. completion date June 2012
Est. primary completion date June 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- adults

Exclusion Criteria:

- aspirin contraindications

- anticoagulants

- aspirin past week

Study Design

Observational Model: Case-Crossover, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States Aggredyne, Inc. Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
Edward R. Teitel, M.D.

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Completed NCT04492423 - VerifyNow® PRUTest® Cardiovascular Population Expected Values On-Drug Study
Completed NCT03355625 - Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients
Completed NCT02958657 - Effect of Exercise on Platelet Reactivity After Myocardial Infarction N/A
Completed NCT01815008 - Pharmacogenomics of Antiplatelet Response - I Phase 4
Completed NCT03039205 - Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor Phase 2
Completed NCT01557335 - A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540 Phase 1
Completed NCT05581238 - Validation of a Red Blood Cell Transfusion Prediction Model in a Low Transfusion Rate Population.
Completed NCT00233428 - Study to Determine Racial and Gender Differences in Platelet Aggregation Phase 1
Completed NCT02112539 - Aggreguide A-100 ADP Assay Evaluation N/A
Completed NCT00923988 - Effect of Passive Smoking on Platelet Function and Endothelial Function N/A
Terminated NCT00748371 - Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration Phase 4
Recruiting NCT05702463 - Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II Phase 1
Recruiting NCT04842760 - PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer
Withdrawn NCT00942617 - Measurement of Platelet Dense Granule Release in Healthy Volunteers N/A
Recruiting NCT06236243 - Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults N/A
Completed NCT00763997 - Study of the Effect of Dipyrone, Ibuprofen, Paracetamol and Parecoxib on the Platelet Aggregation in Analgetic Dosages N/A
Active, not recruiting NCT03615846 - Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan
Completed NCT04369534 - Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction Phase 4
Completed NCT01152229 - Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine N/A
Recruiting NCT03528603 - Acute Assessment of Platelet Reactivity After the Intake of Oleocanthal N/A